Compare Panacea Biotech with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs STERLING BIOTECH - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH STERLING BIOTECH PANACEA BIOTECH/
STERLING BIOTECH
 
P/E (TTM) x 10.5 -0.4 - View Chart
P/BV x 2.2 0.0 15,567.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   STERLING BIOTECH
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
STERLING BIOTECH
Dec-13
PANACEA BIOTECH/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs35411 3,367.6%   
Low Rs1383 4,064.7%   
Sales per share (Unadj.) Rs74.626.8 278.2%  
Earnings per share (Unadj.) Rs6.7-15.0 -44.7%  
Cash flow per share (Unadj.) Rs15.5-5.5 -283.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.254.9 104.2%  
Shares outstanding (eoy) m61.25267.87 22.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.30.3 1,272.0%   
Avg P/E ratio x36.8-0.5 -7,923.0%  
P/CF ratio (eoy) x15.9-1.3 -1,247.3%  
Price / Book Value ratio x4.30.1 3,394.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,0611,862 809.0%   
No. of employees `0002.31.4 170.9%   
Total wages/salary Rs m1,471547 269.0%   
Avg. sales/employee Rs Th1,973.65,303.3 37.2%   
Avg. wages/employee Rs Th635.6403.8 157.4%   
Avg. net profit/employee Rs Th176.8-2,959.0 -6.0%   
INCOME DATA
Net Sales Rs m4,5677,181 63.6%  
Other income Rs m4543 105.2%   
Total revenues Rs m4,6127,223 63.8%   
Gross profit Rs m2,030947 214.4%  
Depreciation Rs m5402,543 21.2%   
Interest Rs m1,0484,377 23.9%   
Profit before tax Rs m486-5,931 -8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-1,924 -4.0%   
Profit after tax Rs m409-4,007 -10.2%  
Gross profit margin %44.413.2 337.0%  
Effective tax rate %15.932.4 48.9%   
Net profit margin %9.0-55.8 -16.1%  
BALANCE SHEET DATA
Current assets Rs m2,41514,335 16.8%   
Current liabilities Rs m9,07749,809 18.2%   
Net working cap to sales %-145.9-494.0 29.5%  
Current ratio x0.30.3 92.4%  
Inventory Days Days65403 16.1%  
Debtors Days Days71171 41.6%  
Net fixed assets Rs m8,33355,432 15.0%   
Share capital Rs m61268 22.9%   
"Free" reserves Rs m3,44313,935 24.7%   
Net worth Rs m3,50414,701 23.8%   
Long term debt Rs m4619,478 4.9%   
Total assets Rs m13,75573,988 18.6%  
Interest coverage x1.5-0.4 -412.4%   
Debt to equity ratio x0.10.6 20.4%  
Sales to assets ratio x0.30.1 342.1%   
Return on assets %10.60.5 2,115.3%  
Return on equity %11.7-27.3 -42.8%  
Return on capital %38.7-6.4 -602.2%  
Exports to sales %20.925.9 80.6%   
Imports to sales %8.10.2 4,793.2%   
Exports (fob) Rs m9541,860 51.3%   
Imports (cif) Rs m37212 3,048.5%   
Fx inflow Rs m1,2031,860 64.7%   
Fx outflow Rs m46725 1,874.9%   
Net fx Rs m7361,835 40.1%   
CASH FLOW
From Operations Rs m1,0491,719 61.0%  
From Investments Rs m-54-3,148 1.7%  
From Financial Activity Rs m-1,0111,426 -70.9%  
Net Cashflow Rs m-20-3 579.4%  

Share Holding

Indian Promoters % 74.5 33.9 219.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.0 -  
FIIs % 1.3 9.9 13.1%  
ADR/GDR % 0.0 16.9 -  
Free float % 23.6 39.3 60.1%  
Shareholders   10,259 21,482 47.8%  
Pledged promoter(s) holding % 35.1 55.9 62.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DR. REDDYS LAB  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling; Sensex Down 235 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Nov 22, 2019 03:19 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS